Research Education Core
研究教育核心
基本信息
- 批准号:10762085
- 负责人:
- 金额:$ 19.72万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-09-24 至 2028-08-31
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
ABSTRACT | RESEARCH EDUCATION CORE
The Research Education Core (REC) of the Ponce Health Sciences University and Moffitt Cancer Center
Partnership has built an educational program that supports participants across the career continuum preparing
them for basic or clinical oncology-related careers. The long-term goal of the REC is to increase the recruitment,
advancement, and quality of cancer research scientists and oncologists from the Puerto Rican and
Hispanic/Latino (H/L) population while advancing health disparities research focused on this population. Through
ongoing interactions with all components of the Partnership, the REC’s educational framework (2007-2022) has
resulted in: 125 participants obtaining faculty, medical, or industry/federal/academic positions with 30 in
hematology-oncology clinical practice; completion of 137 research rotations by PhD, MD or PsyD students;
guidance of 22 Early-Stage Investigators (ESIs); and the creation of new courses, clerkships, and robust cancer
and health disparities seminar series. Leveraging our prior successes the REC strategy is designed to jointly
engage participants across career levels and institutes to create a lasting peer mentoring network which will be
accomplished under the following aims: Aim 1 engages H/L undergraduate students at both PHSU and MCC,
eight total per year, in a new two-year-plus program with year-round mentoring and research experiences
combined with intensive summer research immersion to promote conceptual change in preconceived ideas of
limited opportunities and ‘fit’ for STEM and cancer research. Aim 2 establishes two-year diversity post-doctoral
scholarships at MCC for H/L fellows to support career success with a focus on cancer health disparities and
minority health; and also establishes career development scholarships for late-stage PHSU PhD students to
support career enhancement activities and successful transition to post-doctoral training. Two rolling scholarship
slots are available at each site. The scholarships are interwoven with training in cultural competency,
professionalism, scientific writing, and health disparities to successfully promote a path toward independence.
Aim 3 addresses the need to increase the number of H/L medical residents and medical students entering an
oncology career track. REC will facilitate the creation of the first urology residency program in PR, enable surgical
oncology training at MCC for two PR surgical residents per year, and immerse eight medical students per year
in a summer cancer research experience alongside PhD students. Aim 4 enhances the career development of
ESIs by providing individualized support for each ESI through collaborative interactions, health disparities
training, grant/scientific writing workshops, career development activities, identifying networking opportunities,
and tracking, and evaluating ongoing mentorship and sponsorship. In sum, REC trainees will gain cancer
research and health disparities experience through exposure to Partnership projects and Cores. The REC
outcomes will support the overall Partnership objectives by building and strengthening trainee career pathways
at critical career transition points, resulting in a more diverse pool of oncologists and research scientists.
摘要|研究教育核心
Ponce Health Sciences University和Moffitt癌症中心的研究教育核心(REC)
合作伙伴关系建立了一个教育计划,该计划为整个职业的参与者提供支持
他们从事基本或临床肿瘤有关的职业。 REC的长期目标是增加招聘,
癌症研究科学家和波多黎各和肿瘤学家的进步和质量
西班牙裔/拉丁裔(H/L)人口在进行健康差异研究的同时,集中于这一人群。通过
与合作伙伴关系的所有组成部分进行的持续互动,REC的教育框架(2007-2022)已有
导致:125名参与者获得教职员工,医疗或行业/联邦/学术职位,其中30名
血液学肿瘤临床实践;通过博士,医学博士或PSYD学生完成137次研究轮换;
22个早期研究人员(ESI)的指导;以及创建新课程,文员和良好的癌症
和健康差异精确系列。利用我们先前的成功,REC策略旨在共同
让参与者跨职业级别和机构建立一个持久的同伴心理网络,这将是
根据以下目的完成:AIM 1与PHSU和MCC的H/L本科生参与,
每年总共八个,在一项新的两年以上的计划中,全年心理和研究经验
结合密集的夏季研究沉浸式,以促进概念性变化
有限的机会和对STEM和癌症研究的“适合”。 AIM 2建立了两年多的多样性。
H/L研究员的MCC奖学金,以支持职业成功,重点是癌症健康分布和
少数民族健康;并为晚期PHSU博士学位学生建立职业发展科学
支持职业增强活动,并成功过渡到博士后培训。两个滚动科学
每个站点都有插槽。这些奖学金与文化能力的培训交织在一起,
专业精神,科学写作和健康差异成功地促进了通往独立性的道路。
AIM 3解决了增加H/L医学居民和医学生的数量
肿瘤学职业轨道。 REC将促进PR中的第一个泌尿外科居住计划的创建,启用手术
MCC肿瘤学培训每年两名PR手术居民,每年浸入八名医学生
在夏季癌症研究经验中,博士生。 AIM 4增强了职业发展
通过通过协作互动,健康分布为每个ESI提供个性化支持来通过为每个ESI提供个性化支持
培训,赠款/科学写作研讨会,职业发展活动,确定网络机会,
以及跟踪,并评估正在进行的精通和赞助。总而言之,REC受训者将患癌症
通过接触伙伴关系项目和核心,研究和健康差异经验。 rec
成果将通过建立和加强学员职业道路来支持整体伙伴关系目标
在关键的职业过渡点,导致了更多多样化的肿瘤学家和研究科学家。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
KENNETH Lynn WRIGH...的其他基金
Natural Killer Cell Regulation by PRDM1 and IRF4/8
PRDM1 和 IRF4/8 的自然杀伤细胞调节
- 批准号:85056198505619
- 财政年份:2013
- 资助金额:$ 19.72万$ 19.72万
- 项目类别:
Natural Killer Cell Regulation by PRDM1 and IRF4/8
PRDM1 和 IRF4/8 的自然杀伤细胞调节
- 批准号:86851968685196
- 财政年份:2013
- 资助金额:$ 19.72万$ 19.72万
- 项目类别:
PRDI-BF1 and histone methyltransferase in lymphoma
淋巴瘤中的 PRDI-BF1 和组蛋白甲基转移酶
- 批准号:71010527101052
- 财政年份:2005
- 资助金额:$ 19.72万$ 19.72万
- 项目类别:
PRDI-BF1 and histone methyltransferase in lymphoma
淋巴瘤中的 PRDI-BF1 和组蛋白甲基转移酶
- 批准号:72262767226276
- 财政年份:2005
- 资助金额:$ 19.72万$ 19.72万
- 项目类别:
PRDI-BF1 and histone methyltransferase in lymphoma
淋巴瘤中的 PRDI-BF1 和组蛋白甲基转移酶
- 批准号:69066986906698
- 财政年份:2005
- 资助金额:$ 19.72万$ 19.72万
- 项目类别:
相似海外基金
Methods in Clinical Cancer Research Workshop
临床癌症研究方法研讨会
- 批准号:1072136210721362
- 财政年份:2023
- 资助金额:$ 19.72万$ 19.72万
- 项目类别:
Yale Head and Neck Cancer SPORE Career Enhancement Program
耶鲁大学头颈癌 SPORE 职业提升计划
- 批准号:1066900610669006
- 财政年份:2020
- 资助金额:$ 19.72万$ 19.72万
- 项目类别:
Comparative Modeling of Precision Breast Cancer Control Across the Translational Continuum
跨转化连续体的乳腺癌精准控制的比较模型
- 批准号:1025132610251326
- 财政年份:2020
- 资助金额:$ 19.72万$ 19.72万
- 项目类别:
Comparative Modeling of Precision Breast Cancer Control Across the Translational Continuum
跨转化连续体的乳腺癌精准控制的比较模型
- 批准号:1046914010469140
- 财政年份:2020
- 资助金额:$ 19.72万$ 19.72万
- 项目类别:
Comparative Modeling of Precision Breast Cancer Control Across the Translational Continuum
跨转化连续体的乳腺癌精准控制的比较模型
- 批准号:1045685910456859
- 财政年份:2020
- 资助金额:$ 19.72万$ 19.72万
- 项目类别: